Loading…
meRfi® Microbiome for researchers: Get rapid, structured access to evidence-based gut microbiome literature — organized by disease , intervention, and mechanism, and continuously updated across microbiology, gastroenterology, oncology, immunology, neurology, endocrinology, infectious disease , nutrition science , and pharmacology. Every entry links back to the primary literature with full citations and study details, so you can move from a broad topic overview to the underlying data in seconds. For researchers, doctoral students, and scientific authors, meRfi® Microbiome cuts the time spent on manual PubMed searches and general-purpose AI tools by delivering pre- structured, citation-backed summaries built specifically for theses, reviews, presentations, and publications. A free trial without a credit card makes it easy to see the difference in your own literature search.
Characterization of gut microbial communities, their metabolites (SCFA, bile acids), and the effects of pro- and prebiotics on microbial ecology.
Gut microbiome research in IBD, IBS, colorectal cancer (CRC), NAFLD/MAFLD, and liver cirrhosis — including probiotics, prebiotics, and fecal microbiota transplantation (FMT) as therapeutic strategies.
FMT and defined bacterial consortia in recurrent C. diffcile infection, antibiotic resistance, and microbiome-mediated colonization resistance.
The role of the gut microbiome in obesity, metabolic syndrome, type 2 diabetes, and cardiometabolic risk — plus clinical studies on probiotics, prebiotics, and FMT for glycemic control and lipid metabolism.
Gut-brain axis research on cognition, mood, and neurodegenerative disease, including pro- and prebiotic and FMT studies in depression, dementia, and autism.
The microbiome's role in allergy, autoimmune disease, and immune development; FMT and "biotics" as immunomodulatory strategies.
Microbiome research on carcinogenesis (particularly CRC) and cancer immunotherapy — probiotics, FMT, and defined bacterial consortia to improve response to immune checkpoint inhibitors.
Development of prebiotic fibers, fermented foods, and synbiotic concepts for gut, metabolic, and bone health.
Pharmacomicrobiomics — drug-microbiome interactions and the effect of probiotics and prebiotics on pharmacokinetics and pharmacodynamics.
Across all fields, meRfi® Microbiome gives researchers and doctoral students rapid, structured access to current, evidence-based microbiome literature for theses, presentations, reviews, and publications.
Try meRfi® Microbiome free — no credit card required!
Here you will find a contextualized presentation of inflammatory diseases and the gut microbiota
What are Pathways from Dietary Supplement to Medicine
The need for a new methodological framework to effectively identify key microbiome members
Where these models are used
One of the most promising future strategies in cancer treatment
It covers the reduction of adverse events of cancer therapy and the improvement of its efficacy
Amplified or weakened - they influence the composition of the intestinal microbiota
How engineered and rationally designed bacterial consortia are moving from concept to clinical application